Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neurología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
OBSERVATIONAL
Inicio: 7 de nov de 2011
ID: NCT01468701
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
INTERVENTIONAL
Inicio: 31 de dic de 2006
ID: NCT00412984
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double Blind, Placebo Controlled Parallel-Group Fixed and Flexible SLV308 Dose Arm Study to Assess Efficacy and Safety of SLV308 Monotherapy in the Treatment of Patients With Early Stage Parkinson's Disease
INTERVENTIONAL
Inicio: 1 de jun de 2006
ID: NCT00269516
Reclutando
Fase 1
ClinicalTrials.gov
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Non-arteritic Ischemic Optic Neuropathy
INTERVENTIONAL
Inicio: 1 de feb de 2022
ID: NCT05147701
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Parallel Group, Multi-center Study to Evaluate the Long-term Safety of Salbutamol Rescue Medication When Administered Via Metered Dose Inhalers Containing the Propellant HFA-152a or Reference HFA-134a
INTERVENTIONAL
Inicio: 31 de may de 2024
ID: NCT06261957
Terminado
Fase 3
ClinicalTrials.gov
A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared With Teriflunomide, in Participants With Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety (evolutionRMS 1)
INTERVENTIONAL
Inicio: 12 de jun de 2020
ID: NCT04338022
Reclutando
Fase 2
ClinicalTrials.gov
A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy and Safety of MK-1167 as Adjunctive Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia
INTERVENTIONAL
Inicio: 16 de dic de 2024
ID: NCT06721156
Completado
Fase 4
ClinicalTrials.gov
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
INTERVENTIONAL
Inicio: 7 de ene de 2015
ID: NCT02255656
Completado
ClinicalTrials.gov
Multicenter Observational Cohort Study to Evaluate Cerebral AneurysmFlow Results in Occlusion
OBSERVATIONAL
Inicio: 4 de oct de 2018
ID: NCT03663257
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-Blind, Placebo-Controlled, International, Multicentre, Phase III Study to Investigate the Efficacy and Safety of Ticagrelor and ASA Compared With ASA in the Prevention of Stroke and Death in Patients With Acute Ischaemic Stroke or Transient Ischaemic Attack
INTERVENTIONAL
Inicio: 22 de ene de 2018
ID: NCT03354429
Reclutando
ClinicalTrials.gov
Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
OBSERVATIONAL
Inicio: 2 de ene de 2024
ID: NCT07159750
Completado
Fase 2
ClinicalTrials.gov
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
INTERVENTIONAL
Inicio: 1 de nov de 2009
ID: NCT00887588
Completado
ClinicalTrials.gov
Sensory Processing and Pain Modulatory Mechanisms Associated With Characteristics of the Infraspinatus Muscle in Individuals With and Without Shoulder Pain
INTERVENTIONAL
Inicio: 1 de abr de 2022
ID: NCT05368649
Reclutando
Fase 3
ClinicalTrials.gov
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Eptinezumab in Paediatric Patients (6 to 17 Years) for the Preventive Treatment of Episodic Migraine
INTERVENTIONAL
Inicio: 8 de jun de 2023
ID: NCT05897320
Completado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel Group, Dose Response Study of Subcutaneous AVE5026 With an Enoxaparin Calibrator Arm in the Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery
INTERVENTIONAL
Inicio: 1 de may de 2006
ID: NCT00331838
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
INTERVENTIONAL
Inicio: 15 de feb de 2023
ID: NCT05702034
Terminado
ClinicalTrials.gov
Integration of Electronic SBI(RT) Into an HIV Testing Program to Reduce Substance Use and HIV Risk Behavior Among MSM in Argentina
INTERVENTIONAL
Inicio: 1 de nov de 2022
ID: NCT05542914
Completado
ClinicalTrials.gov
Healthy Habits Program for High Cardiovascular Risk Patients: Randomized Controlled Clinical Trial. Effectiveness of a Program Using Cognitive Behavioral Therapy to Improve Healthy Habits in a Population With Cardiovascular Disease.
INTERVENTIONAL
Inicio: 1 de jun de 2013
ID: NCT01861977
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
INTERVENTIONAL
Inicio: 22 de dic de 2021
ID: NCT05269394
Completado
ClinicalTrials.gov
A 54-week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) as Adjunctive Therapy to Donepezil on Cognition and Overall Clinical Response in APOE ε4-stratified Subjects With Mild to Moderate Alzheimer's Disease.
INTERVENTIONAL
Inicio: 6 de jul de 2006
ID: NCT00348309
Anterior
1
...
26
27
28
...
434
Siguiente
Filtros